News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Noxopharm.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s breaking their silence today?
Health & Biotech
ASX Health Stocks: ResApp jumps 65pc on smartphone Covid-19 cough tests
News
Top 10 at 10: Which ASX stock is king of the pack today?
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Closing Bell: The ASX lifts with all sectors finishing in the green
Health & Biotech
Check up: 78 biotech companies rocked the boat this week but only one has real news
Health & Biotech
ASX Health Stocks: Opthea and Alterity to present at world renowned biotech conference
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Virtus is being pursued as Bionomics prepares for dual Nasdaq listing
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
Health & Biotech
ASX Health Stocks: Amplia eyes human trials for pancreatic cancer drug
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: Noxopharm gets initial nod for patent, Rhythm tops 11pc on imminent market launch
Health & Biotech
ASX Health Stocks: Invex jumps 14pc after deal in Korea, Noxopharm gets US Patent nod
Health & Biotech
ASX health stocks: Shares in cancer-fighting company Noxopharm edge higher following its full-year results
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
News
